Cargando…
Heterogeneous global health stock and growth: quantitative evidence from 140 countries, 1990–2100
BACKGROUND: In the prevailing economic perspective, health is viewed as a type of capital stock that yields ‘healthy days’ in human society. However, evaluations of this health capital stock are still limited to specific contexts. The primary aim of this study is to measure and forecast the global h...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6309060/ https://www.ncbi.nlm.nih.gov/pubmed/30607246 http://dx.doi.org/10.1186/s13690-018-0327-8 |
_version_ | 1783383330882846720 |
---|---|
author | Jumbri, Isma Addi Ikeda, Shinya Managi, Shunsuke |
author_facet | Jumbri, Isma Addi Ikeda, Shinya Managi, Shunsuke |
author_sort | Jumbri, Isma Addi |
collection | PubMed |
description | BACKGROUND: In the prevailing economic perspective, health is viewed as a type of capital stock that yields ‘healthy days’ in human society. However, evaluations of this health capital stock are still limited to specific contexts. The primary aim of this study is to measure and forecast the global health stocks in 140 countries from 1990 to 2100. METHODS: The health capital stock in each country from 1990 to 2015 was estimated using a capital approach. The future health stocks between 2016 and 2100 were forecast using a time-series model. RESULTS: Based on the health stocks from 1990 to 2015, low-income countries have much larger and more rapidly growing health stocks. In the long-term, to 2100, upper-middle income countries, particularly countries in the Middle East and North Africa, exhibit great growth that benefits from the peaks in their youth or working-age populations. Immigration also contributes to health stock growth, as do other factors, e.g., the fertility rate, population ageing, and working-age and youth populations. CONCLUSIONS: Health stock is a vital component of global sustainable development that should be consistently included as a stock-based sustainability index in the evaluations of other capital to accurately measure national wealth and sustainability. |
format | Online Article Text |
id | pubmed-6309060 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-63090602019-01-03 Heterogeneous global health stock and growth: quantitative evidence from 140 countries, 1990–2100 Jumbri, Isma Addi Ikeda, Shinya Managi, Shunsuke Arch Public Health Research BACKGROUND: In the prevailing economic perspective, health is viewed as a type of capital stock that yields ‘healthy days’ in human society. However, evaluations of this health capital stock are still limited to specific contexts. The primary aim of this study is to measure and forecast the global health stocks in 140 countries from 1990 to 2100. METHODS: The health capital stock in each country from 1990 to 2015 was estimated using a capital approach. The future health stocks between 2016 and 2100 were forecast using a time-series model. RESULTS: Based on the health stocks from 1990 to 2015, low-income countries have much larger and more rapidly growing health stocks. In the long-term, to 2100, upper-middle income countries, particularly countries in the Middle East and North Africa, exhibit great growth that benefits from the peaks in their youth or working-age populations. Immigration also contributes to health stock growth, as do other factors, e.g., the fertility rate, population ageing, and working-age and youth populations. CONCLUSIONS: Health stock is a vital component of global sustainable development that should be consistently included as a stock-based sustainability index in the evaluations of other capital to accurately measure national wealth and sustainability. BioMed Central 2018-12-28 /pmc/articles/PMC6309060/ /pubmed/30607246 http://dx.doi.org/10.1186/s13690-018-0327-8 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Jumbri, Isma Addi Ikeda, Shinya Managi, Shunsuke Heterogeneous global health stock and growth: quantitative evidence from 140 countries, 1990–2100 |
title | Heterogeneous global health stock and growth: quantitative evidence from 140 countries, 1990–2100 |
title_full | Heterogeneous global health stock and growth: quantitative evidence from 140 countries, 1990–2100 |
title_fullStr | Heterogeneous global health stock and growth: quantitative evidence from 140 countries, 1990–2100 |
title_full_unstemmed | Heterogeneous global health stock and growth: quantitative evidence from 140 countries, 1990–2100 |
title_short | Heterogeneous global health stock and growth: quantitative evidence from 140 countries, 1990–2100 |
title_sort | heterogeneous global health stock and growth: quantitative evidence from 140 countries, 1990–2100 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6309060/ https://www.ncbi.nlm.nih.gov/pubmed/30607246 http://dx.doi.org/10.1186/s13690-018-0327-8 |
work_keys_str_mv | AT jumbriismaaddi heterogeneousglobalhealthstockandgrowthquantitativeevidencefrom140countries19902100 AT ikedashinya heterogeneousglobalhealthstockandgrowthquantitativeevidencefrom140countries19902100 AT managishunsuke heterogeneousglobalhealthstockandgrowthquantitativeevidencefrom140countries19902100 |